======= SMNDC1 ======= == Gene Information == * **Official Symbol**: SMNDC1 * **Official Name**: survival motor neuron domain containing 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10285|10285]] * **UniProt**: [[https://www.uniprot.org/uniprot/O75940|O75940]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SMNDC1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SMNDC1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/603519|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene is a paralog of SMN1 gene, which encodes the survival motor neuron protein, mutations in which are cause of autosomal recessive proximal spinal muscular atrophy. The protein encoded by this gene is a nuclear protein that has been identified as a constituent of the spliceosome complex. This gene is differentially expressed, with abundant levels in skeletal muscle, and may share similar cellular function as the SMN1 gene. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Necessary for spliceosome assembly. Overexpression causes apoptosis. {ECO:0000269|PubMed:11331295, ECO:0000269|PubMed:11331595, ECO:0000269|PubMed:9817934}. |SMN| |Cajal body| |spliceosomal complex| |mRNA splicing, via spliceosome| |RNA splicing, via transesterification reactions with bulged adenosine as nucleophile| |RNA splicing, via transesterification reactions| |RNA splicing| |nuclear speck| |mRNA processing| |mRNA metabolic process| |RNA processing| |apoptotic process| |programmed cell death| |cell death| |RNA binding| |RNA metabolic process| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp256|HMS-I1 10μM R06 exp256]]|-2.19| |[[:results:exp517|Quercetin 20μM R08 exp517]]|-1.94| |[[:results:exp532|TIC10 10μM R08 exp532]]|-1.79| |[[:results:exp288|HMS-I2 10μM R06 exp288]]|1.71| |[[:results:exp419|Tunicamycin 0.04 to 0.075μM on day4 R07 exp419]]|1.74| |[[:results:exp418|Tunicamycin 0.04μM R07 exp418]]|1.76| |[[:results:exp12|Chloramphenicol 2μM R00 exp12]]|1.82| |[[:results:exp405|Tenofovir 10μM R07 exp405]]|1.83| |[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|1.89| |[[:results:exp389|PF-06409577 20μM R07 exp389]]|1.94| |[[:results:exp317|Geldanamycin 0.015 to 0.05μM on day4 R07 exp317]]|2.41| ^Gene^Correlation^ |[[:human genes:p:prpf3|PRPF3]]|0.425| Global Fraction of Cell Lines Where Essential: 348/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|0/1| |bile duct|13/28| |blood|5/28| |bone|13/25| |breast|15/33| |central nervous system|32/56| |cervix|2/4| |colorectal|9/17| |esophagus|1/13| |fibroblast|1/1| |gastric|6/15| |kidney|4/21| |liver|9/20| |lung|46/75| |lymphocyte|13/14| |ovary|15/26| |pancreas|9/24| |peripheral nervous system|8/16| |plasma cell|11/15| |prostate|0/1| |skin|11/24| |soft tissue|2/7| |thyroid|1/2| |upper aerodigestive|7/22| |urinary tract|18/29| |uterus|3/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1318 * **Expression level (log2 read counts)**: 5.77 {{:chemogenomics:nalm6 dist.png?nolink |}}